Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2795)
All Articles published online
|
Publishing Process of This Article
|
Mar 24, 2024 (publication date) through Sep 27, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Oncology
ISSN
2218-4333
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Yadav BS. High-dose methotrexate and zanubrutinib combination therapy for primary central nervous system lymphoma. World J Clin Oncol 2024; 15(3): 371-374 [PMID: 38576595 DOI: 10.5306/wjco.v15.i3.371] |
|---|---|
| URL: | https://www.wjgnet.com/2218-4333/full/v15/i3/371.htm |
| Number | Citing Articles |
| 1 |
Mohammad Amin Akbarzadeh, Mahsa Akbarzadeh, Yosra Vaez-Gharamaleki, Mohammad-Salar Hosseini. Long-Term Outcomes and Potential Late-Onset Side Effects of Combination Therapy in Older Immunocompromised Patients Treated for COVID-19. International Journal of Drug Research in Clinics 2024; 2: e28 doi: 10.34172/ijdrc.2024.e28
|